SCHEMBL9103827

SCHEMBL9103827

Cn1c(=O)c(-c2cc(C(=O)O)ccc2Cl)cc2cnnc(-c3ccc(F)cc3F)c21

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1311772 0.81 MAPK14 (1.00) MAPK14
SCHEMBL1311125 0.81 MAPK14 (0.66) MAPK14
SCHEMBL1311225 0.80 MAPK14 (1.00) MAPK14
SCHEMBL1313572 0.79 MAPK14 (0.61) MAPK14
SCHEMBL1310604 0.78 MAPK14 (1.00) MAPK14
SCHEMBL1310858 0.78 MAPK14 (0.80) MAPK14
SCHEMBL1310738 0.77 MAPK14 (0.82) MAPK14
SCHEMBL1313213 0.77 MAPK14 (1.00) MAPK14
SCHEMBL1311179 0.77 MAPK14 (0.84) MAPK14
SCHEMBL10286418 0.77 MAPK14 (0.71) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334674-B1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. AMGEN INC (US) 2012-06-06 EP disclosed